In-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.
about
Neutralizing anti-interleukin-1β antibodies modulate fetal blood-brain barrier function after ischemia.Interleukin-1β transfer across the blood-brain barrier in the ovine fetus.Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.Interferon-γ: Promising therapeutic target in atherosclerosis.Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus.Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep.
P2860
In-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
In-vitro validation of cytokin ...... ovine mononuclear splenocytes.
@ast
In-vitro validation of cytokin ...... ovine mononuclear splenocytes.
@en
type
label
In-vitro validation of cytokin ...... ovine mononuclear splenocytes.
@ast
In-vitro validation of cytokin ...... ovine mononuclear splenocytes.
@en
prefLabel
In-vitro validation of cytokin ...... ovine mononuclear splenocytes.
@ast
In-vitro validation of cytokin ...... ovine mononuclear splenocytes.
@en
P2093
P2860
P1476
In-vitro validation of cytokin ...... ovine mononuclear splenocytes.
@en
P2093
B S Stonestreet
E E Cummings
G B Sadowska
J F Padbury
S W Threlkeld
P2860
P304
P356
10.1016/J.JCPA.2012.06.001
P577
2012-07-20T00:00:00Z